van BurikJ.A., CarterS.L., FreifeldA.G.Higher risk of cytomegalovirus and Aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant.2007; 13(12): 1487–1498.
3.
GoodmanJ.L., WinstonD.J., GreenfieldR.A.A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med.1992; 326(13): 845–851.
4.
SlavinM.A., OsborneB., AdamsR.Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis.1995; 171(6): 1545–1552.
5.
MarrK.A., CrippaF., LeisenringW.Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood.2004; 103(4): 1527–1533.
6.
CornelyO.A., MaertensJ., WinstonD.J.Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med.2007; 356(4): 348–359.
7.
UllmannA.J., LiptonJ.H., VesoleD.H.Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med.2007; 356(4): 335–347.
8.
WalshT.J., AnaissieE.J., DenningD.W.Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis.2008; 46(3): 327–360.
9.
WenzelR., Del FaveroA., KibblerC.Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. J Antimicrob Chemother.2005; 55(3): 352–361.
10.
DasbachE.J., DaviesG.M., TeutschS.M.Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis.2000; 31(6): 1524–1528.
11.
ZaoutisT.E., HeydonK., ChuJ.H., WalshT.J., SteinbachW.J.Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics.2006; 117(4): e711–e716.
12.
VandewoudeK.H., BlotS.I., BenoitD., ColardynF., VogelaersD.Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect.2004; 56(4): 269–276. ■
